← Back to headlines
European Medicines Agency Begins Review of First Human Lyme Disease Vaccine
A significant step has been taken in the fight against Lyme disease as the European Medicines Agency (EMA) begins evaluating the application for a vaccine candidate developed by Pfizer and Valneva, which could become the first human vaccine against the disease in Europe if approved.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
